Yang Ping, Liang Gaoli, Ni Yangyue, Chu Xiaojie, Zhang Xiaoshan, Wang Zhongyu, Khan Adeel, Jin Fangfang, Shen Han, Li Miao, Xu Zhipeng
Department of Clinical Laboratory, Nanjing Drum Tower Hospital Clinical College of Xuzhou Medical University, Nanjing, 210008, China.
State Key Laboratory of Pharmaceutical Biotechnology, Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, NJU Advanced Institute of Life Sciences (NAILS), Nanjing University, Nanjing, 210008, Jiangsu, P. R. China.
J Transl Med. 2025 Jan 28;23(1):126. doi: 10.1186/s12967-025-06142-w.
Growing evidence implicates that intratumoral microbiota are closely linked to cancer progression; however, research on the role of these microbiota in the development of gastric cancer remains limited. Here, using 16 S rRNA sequencing, tumor tissue proteomics and serum cytokines analysis, we identified enrichment of specific microbial communities within tumors of gastric cancer patients, possibly affecting the tumor microenvironment by immune modulation, metabolic processes, and inflammatory responses. Based on the results of in vivo experiments and intratumoral microbiota analysis, we found that Streptococcus mitis can inhibit gastric cancer progression via suppressing M2 macrophage polarization and infiltration, as well as altering the intratumoral microbial community. In summary, our findings suggest that the intratumoral microbiota, exemplified by Streptococcus mites, may be involved in regulating the progression of gastric cancer, thereby emerging as potential therapeutic targets for this disease.
越来越多的证据表明,肿瘤内微生物群与癌症进展密切相关;然而,关于这些微生物群在胃癌发生发展中的作用的研究仍然有限。在这里,我们通过16S rRNA测序、肿瘤组织蛋白质组学和血清细胞因子分析,确定了胃癌患者肿瘤内特定微生物群落的富集,这些微生物群落可能通过免疫调节、代谢过程和炎症反应影响肿瘤微环境。基于体内实验和肿瘤内微生物群分析的结果,我们发现缓症链球菌可通过抑制M2巨噬细胞极化和浸润以及改变肿瘤内微生物群落来抑制胃癌进展。总之,我们的研究结果表明,以缓症链球菌为代表的肿瘤内微生物群可能参与调节胃癌的进展,从而成为这种疾病潜在的治疗靶点。